197 related articles for article (PubMed ID: 11223018)
1. COMT-dependent protection of dopaminergic neurons by methionine, dimethionine and S-adenosylmethionine (SAM) against L-dopa toxicity in vitro.
Werner P; Di Rocco A; Prikhojan A; Rempel N; Bottiglieri T; Bressman S; Yahr MD
Brain Res; 2001 Mar; 893(1-2):278-81. PubMed ID: 11223018
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
[TBL] [Abstract][Full Text] [Related]
4. L-dopa upregulates the expression and activities of methionine adenosyl transferase and catechol-O-methyltransferase.
Zhao WQ; Latinwo L; Liu XX; Lee ES; Lamango N; Charlton CG
Exp Neurol; 2001 Sep; 171(1):127-38. PubMed ID: 11520127
[TBL] [Abstract][Full Text] [Related]
5. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
Brannan T; Prikhojan A; Yahr MD
J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
[TBL] [Abstract][Full Text] [Related]
6. 3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA.
Asanuma M; Miyazaki I
BMC Neurosci; 2016 Jul; 17(1):52. PubMed ID: 27456338
[TBL] [Abstract][Full Text] [Related]
7. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
8. A semiempirical study on inhibition of catechol O-methyltransferase by substituted catechols.
Ovaska M; Yliniemelä A
J Comput Aided Mol Des; 1998 May; 12(3):301-7. PubMed ID: 9749372
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase decreases levodopa toxicity in vitro.
Offen D; Panet H; Galili-Mosberg R; Melamed E
Clin Neuropharmacol; 2001; 24(1):27-30. PubMed ID: 11290879
[TBL] [Abstract][Full Text] [Related]
10. Regulation of dopamine-induced natriuresisby the dopamine-metabolizing enzyme catechol-O-methyltransferase.
Odlind C; Göransson V; Reenilä I; Hansell P
Exp Nephrol; 1999; 7(4):314-22. PubMed ID: 10450019
[TBL] [Abstract][Full Text] [Related]
11. Effects of L-dopa treatment on methylation in mouse brain: implications for the side effects of L-dopa.
Liu XX; Wilson K; Charlton CG
Life Sci; 2000; 66(23):2277-88. PubMed ID: 10855949
[TBL] [Abstract][Full Text] [Related]
12. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, reduces the peripheral O-methylation of L-DOPA and enhances its availability to the brain.
Parada A; Soares-da-Silva P
Pharmacology; 2003 May; 68(1):29-37. PubMed ID: 12660477
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and analysis of novel catecholic ligands as inhibitors of catechol-O-methyltransferase.
Katherine Hatstat A; Kennedy GM; Squires TR; Xhafkollari G; Skyler Cochrane C; Cafiero M; Peterson LW
Bioorg Med Chem Lett; 2023 May; 88():129286. PubMed ID: 37054761
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase inhibition in erythrocytes and liver by BIA 3-202 (1-[3,4-dibydroxy-5-nitrophenyl]-2-phenyl-ethanone).
Soares-da-Silva P; Vieira-Coelho MA; Parada A
Pharmacol Toxicol; 2003 Jun; 92(6):272-8. PubMed ID: 12787259
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
Masjost B; Ballmer P; Borroni E; Zürcher G; Winkler FK; Jakob-Roetne R; Diederich F
Chemistry; 2000 Mar; 6(6):971-82. PubMed ID: 10785817
[TBL] [Abstract][Full Text] [Related]
16. The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells.
Suriguga ; Li XF; Li Y; Yu CH; Li YR; Yi ZC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):635-43. PubMed ID: 24141029
[TBL] [Abstract][Full Text] [Related]
17. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons.
Cheng N; Maeda T; Kume T; Kaneko S; Kochiyama H; Akaike A; Goshima Y; Misu Y
Brain Res; 1996 Dec; 743(1-2):278-83. PubMed ID: 9017256
[TBL] [Abstract][Full Text] [Related]
18. Crystal Structure of Catechol O-Methyltransferase Complexed with Nitecapone.
Iijima H; Takebe K; Suzuki M; Kobayashi H; Takamiya T; Saito H; Niwa N; Kuwada-Kusunose T
Chem Pharm Bull (Tokyo); 2020; 68(5):447-451. PubMed ID: 32378542
[TBL] [Abstract][Full Text] [Related]
19. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
[TBL] [Abstract][Full Text] [Related]
20. Distribution, properties, and inhibitor sensitivity of zebrafish catechol-O-methyl transferases (COMT).
Semenova S; Rozov S; Panula P
Biochem Pharmacol; 2017 Dec; 145():147-157. PubMed ID: 28844929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
